- Exchange: Korea SE
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Chong Kun Dang Pharm Corp
+ Add to Watchlist001630:KS
56,200 KRW 100 0.18%As of 02:12:41 ET on 05/24/2013.
Snapshot for Chong Kun Dang Pharm Corp (001630)
| Open: | 56,400 | Day's Range: | 54,300 - 56,900 | Volume: | 99,188 |
|---|---|---|---|---|---|
| Previous Close: | 56,300 | 52wk Range: | 13,800 - 64,400 | 1-Yr Rtn: | +306.13% |
Key Statistics for 001630
| Current P/E Ratio (ttm) | 21.3932 |
|---|---|
| Estimated P/E(12/2013) | 11.5567 |
| Relative P/E vs. KOSPI | 0.8226 |
| Earnings Per Share (KRW) (ttm) | 2,627.0000 |
| Est. EPS (KRW) (12/2013) | 4,863.0000 |
| Est. PEG Ratio | - |
| Market Cap (M KRW) | 733,410.00 |
| Shares Outstanding (M) | 13.05 |
| 30 Day Average Volume | 130,940 |
| Price/Book (mrq) | 1.9101 |
| Price/Sale (ttm) | 1.1498 |
| Dividend Indicated Gross Yield | 1.25% |
| Cash Dividend (KRW) | 700.0000 |
| Last Dividend | 12/27/2012 |
| 5 Year Dividend Growth | 48.42% |
| Next Earnings Announcement | 02/06/2014 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 001630
Company Profile & Key Executives for 001630
Chong Kun Dang Pharmaceutical Corporation manufactures pharmaceutical products. The Company produces medical drugs in the fields of systemic anti-infective, cardiovascular system, alimentary tract, metabolism, and sensory organs.
| Rhee Jang-HanChairman/CEO/Co-Rep Director | Kim Yeong-EunVice Chairman |
| Kim Jung-WooPresident/Co-Rep Director | Kim Seong-NamSenior Managing Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
001630 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page